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Abstract
Background: Our study was aimed to validate a modified RBD (REM sleep behavior disorder) single question
(RBD1Q-C), study the prevalence of probable RBD (pRBD) in a rural community based on RBD1Q-C and investigate
the association between pRBD and Parkinson’s disease (PD).
Methods: The validation study of RBD1Q-C included 32 Chinese participants (14 idiopathic RBD patients and 18
controls). All participants underwent a polysomnogram (PSG). We then conducted a door-to-door survey to
estimate the prevalence of pRBD assessed by RBD1Q-C, and its association with PD among 19614 residents who
lived in Malu community of Shanghai, China.
Results: RBD1Q-C demonstrated a high sensitivity of 100 %, a moderate specificity of 55.6 %. The agreement
between RBD1Q-C and PSG-based RBD diagnosis was good (k = 0.552). PPV of the RBD1Q-C was 63.6 % and NPV
was 100 %. The prevalence of pRBD in Malu community was 4.9 %. In people over 50 years old, presence of pRBD
was significantly associated with increased risk of having PD (odds ratio = 2.61, 95 % CI: 1.56–4.39).
Conclusion: RBD1Q-C was shown to be a useful screening tool. Based on the RBD1Q-C, we found that pRBD was
not rare in Chinese rural population and associated with odds of PD, calling for more attention from patients,
caregivers and physicians.
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Background
Rapid eye movement (REM) sleep behavior disorder (RBD)
is a parasomnia characterized by dream enactment behav-
iors in the setting of increased electromyographic activity
during REM sleep [1]. These dream enactment behaviors
occur almost always in the setting of an upsetting dream
and present as sleep talking, shouting, and vigorous or elab-
orate body movements including punching, kicking, sitting
up, and even falling out of bed [2]. Recent studies found
that RBD may represent an early clinical manifestation of a
developing neurodegenerative disorders, mostly synucleino-
pathies such as PD (Parkinson’s disease), MSA (multiple
system atrophy) and DLB (Lewy Body Dementia) [3–6]. Re-
liable, accurate methods for identifying RBD may offer a
window for early intervention.
Polysomnographic (PSG) is required for the diagnosis
of RBD according to the third edition of the Inter-
national Classification of Sleep Disorders (ICSD-III).
However, PSGs are time and resource consuming. The
REM Sleep Behavior Disorder Single-Question Screen
(RBD1Q) was developed and validated to be an easily
applicable and short diagnostic screening tool [7]. The
RBD1Q can detect RBD with 94 % sensitivity and 87 %
specificity in a well-characterized, clinic-based cohort of
RBD patients and controls.
Because of concerns about the specificity, RBD1Q does
not screen for sleep talking or sleep yelling. While the sin-
gle item analysis of Innsbruck RBD inventory (RBD-I) re-
vealed that sleep-related vocalization (sleep talking not
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included) had a good specificity of 94.2 % and AUC
(0.804) [8]. In consideration of a subset of patients for
whom this is the only manifestation, we modified RBD1Q
into a Chinese version of RBD1Q (RBD1Q-C) with the in-
clusion of sleep screaming and sleep yelling in order to
obtain a higher sensitivity for the screening purpose. In
addition, as the prevalence of RBD and the association of
RBD with neurodegenerative diseases has not been well
studied in Chinese general population [9–11], we aimed in
this study to (1) validate the modified RBD1Q (RBD1Q-
C); (2) estimate prevalence of probable RBD (pRBD) in a
population-based survey by using RBD1Q-C as a screen-
ing tool; and (3) examine whether pRBD based on
RBD1Q-C was associated with Parkinson’s disease.
Methods
Screening question
RBD1Q was translated and back-translated by a senior
neurologist and a professional translator. Then we in-
cluded sleep shouting or yelling into the question, named
as Chinese version of RBD1Q (RBD1Q-C). RBD1Q-C
consists of a single question, answered “yes” or “no,” as
follows “Did you have the following conditions (or have
you ever been told by your husband or wife) that you
shout, yell, move your arms or legs in response to your
dream contents, even fallen off your bed?” (Additional
file 1). This question was designed to be self-administered,
with participation by caregivers encouraged.
Participants
For validation study of RBD1Q-C
Patients referred to the Departments of Respiratory and
Neurology for sleep complaints were recruited in this
study based on consequential sampling. People who
were unwilling or unable to participate (such as hearing
problems) were excluded. People were asked to complete
the RBD1Q-C before PSG study after consent. Therefore
they did not know their final diagnosis when they com-
pleted the questionnaire. All RBD patients had RBD
diagnosis confirmed by history and PSG according to
the ICSD-III. And patients were classified as the control
group who did not meet the RBD diagnosis based on
PSG and history. Patients who failed to attain REM sleep
on their PSG were excluded from the study.
For pRBD prevalence study
This door-to-door study was conducted in Malu com-
munity of Jiading district which is located in north-west
rural area of Shanghai from April to October 2013. Ac-
cording to the censorship, there are 45353 residents
aged ≥20 years. About 31202 (68.8 %) residents com-
pleted RBD1Q-C. pRBD diagnosis was based on RBD1Q
without PSG study. Therefore, we used pRBD instead of
RBD in our study.
For PD ascertainment
We did a two-step door-to-door study to screen PD pa-
tients in people aged 50 years or older in Malu community
to examine whether RBD was associated with PD. In the
first step, local doctors from medical center of Malu com-
munity had one-day clinical teaching course of evaluating
parkinsonism and essential tremor by movement disorders
specialists from the Department of Neurology, Rui Jin
Hospital affiliated to Shanghai Jiao Tong University School
of Medicine. This clinical teaching course included video
presentation of symptoms of parkinsonism and essential
tremor and how to retrieve the history. Under the supervi-
sion of movement disorder specialist, local doctor was con-
sidered qualified when they demonstrated competency to
do the clinical examination of tremor, bradykinesia, rigidity
and gait. After being trained, these local doctors visited resi-
dents ≥50 years from door to door and reported possible
parkinsonism cases to the movement disorder specialists.
In the second step, movement disorder specialists revisited
these possible parkinsonism cases to made the final diagno-
sis which included imaging studies, routine exclusion of
other parkinsonian disorders such as multiple system atro-
phy, progressive supranuclear palsy, or cortico-basal degen-
eration, etc. The diagnosis of PD patients was based on the
United Kingdom Parkinson’s Disease Society Brain Bank
Clinical Diagnostic Criteria.
Statistical analysis
Analysis was carried out by using IBM SPSS Statistics
Version 17.0 (SPSS, Chicago, IL). For validation study of
RBD1Q-C, demographic feature of participants were
compared by student t test and χ2 test. The psychomet-
ric properties of the RBD1Q-C were assessed by calcu-
lating the sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV) for each
threshold with a 95 % confidence interval (CI). The diag-
nostic value of RBD1Q-C was calculated by the area
under the curve (AUC). The agreement (k coefficent) of
RBD1Q-C with PSG was calculated. k values were used
to categorize results as very good (0.81–1.0), good
(0.61–0.8), moderate (0.41–0.6), fair (0.21–0.4) or poor
(0–0.2). The Fisher exact test was used to compare the
detection rate between the RBD1Q-C and PSG-based
RBD diagnosis and a p value <0.05 was considered sig-
nificantly different.
To estimate the association between pRBD and PD, we
used logistic regression model to calculate odds ratio
(OR) with 95 % confidence interval (95 % CI), according
to pRBD status, adjusting for age and sex.
Results
Validation of RBD1Q-C
A total of 139 participants with sleep complaints were
enrolled (26–87 year, 47 female and 92 male). These
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patients were not on medication associated with RBD
such as SSRI antidepressant. People on benzodiazepine
were asked to stop medication for at least one week to
perform the PSG test. About 46 subjects were excluded
because of lack REM sleep during v-PSG or technical
problems (10 PD with RBD, 1 iRBD, 12 OSAS, 8 insom-
nia, 5 RLS, 3 epilepsy, 7 others). Among 93 remaining
subjects, 36 were diagnosed as RBD (20 PD with RBD, 2
MSA with RBD, and 14 idiopathic RBD) and 57 non-RBD
(2 PD without RBD, 4 Restless legs syndrome, 26 OSAS
(10 severe OSAS), 8 Epilepsy, 1 subdural hemorrhage, 1
dementia with insomnia, 8 insomnia, and 8 others). We
included totally 32 subjects into our validation study: 14
idiopathic RBD patients and 18 non-RBD controls (1 sub-
dural hemorrhage, 1 dementia with insomnia, 8 insomnia
and 8 others). Mean RBD patient age was 64.07 ±
4.62 years old, in comparable to non-RBD group (60.39 ±
13.00) (p = 0.32). About 50 % of RBD patients were men,
compared to 66.7 % of controls (p = 0.47).
In 14 RBD patients, 14 answered “yes” to RBD1Q-C,
translating to a sensitivity of 100 % (95 %CI: 73.2–
100 %) and 10 out of 18 non-RBD answered “no” to
RBD1Q-C, translating to a specificity of 55.6 % (95 % CI:
31.3–77.6 %). Area under the receiver operating charac-
teristic (ROC) curve was 0.778 (95 % CI: 0.615–0.940).
The agreement between RBD1Q-C and PSG-based RBD
was good (k = 0.552). The positive predictive value
(PPV) of the RBD1Q-C was 63.6 % (95 % CI: 40.8–
82.0 %) and negative predictive value (NPV) was 100 %
(95 % CI: 65.5–100 %).
Prevalence of pRBD
There were 1521 of 31202 participants who answered
“yes” to RBD1Q-C. Among the 1521 residents, 612 were
men (40.2 %), 909 were women (59.8 %), the mean age
was 66.53 ± 11.48 years (range 20–99). The crude preva-
lence of pRBD (diagnosis of pRBD was based on RBD1Q
without PSG confirming) in Malu community was esti-
mated to be 4.9 % (95 % CI: 4.6–5.1 %), significantly
higher for women than men (5.6 vs. 4.1 %, p < 0.001).
For both men and women, the prevalence of pRBD in-
creased with age and reached the peak in the 70–79 age
population (Table 1).
RBD and PD
Totally 19614 people over 50 years old answered RBD1Q-C
questionnaire (1428 answered “yes” and 18186 answered
“no”) and examined by local doctors and further movement
disorders specialists for PD diagnosis. After first screen, 124
subjects were diagnosed as parkinsonism by local doctors.
Movement disorders specialist revisited 124 subjects and
made the final diagnosis of PD in 97 subjects. Prevalence of
PD was 1.2 % among those with pRBD and 0.4 % among
those without pRBD (age-and sex-adjusted OR= 2.61, 95 %
CI: 1.56–4.39, P < 0.001).
Table 1 Population and prevalence of RBD by age and gender in Malu community
Age(yr) Men Women Total
n % n % n %
Population
20–49 5779 18.5 5809 18.6 11588 37.1
50–59 3108 10.0 3073 9.8 6181 19.8
60–69 3372 10.8 3698 11.9 7070 22.7
70–79 1625 5.2 1779 5.7 3404 10.9
80– 1173 3.8 1786 5.7 2959 9.5
Total 15057 48.3 16145 51.7 31202 100.0
Prevalence of RBD
20–49 40 0.7
95 % CI: 0.5–0.9
53 0.9
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Table 2 Characteristics of six validated screening tools of RBD
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Our study demonstrated that RBD1Q-C was reliable to
screen potential RBD in large epidemiological study. The
prevalence of pRBD diagnosed by RBD1Q-C was 4.9 %,
higher in women than men. pRBD was associated with
PD in people over 50 years.
Regarding to the importance of RBD in synucleinopa-
thies and the difficulty to perform PSG, a few RBD
screening questionnaires have been designed to facilitate
population-based studies which included RBD1Q-C,
REM sleep behavior disorder screening questionnaire
(RBDSQ), RBDQ-HK (Hong Kong), Mayo Sleep ques-
tionnaire (MSQ) and Innsbruck RBD inventory (RBD-I)
[8, 12–14]. So far, RBDSQ and RBDQ-HK have been val-
idated in China [15, 16]. RBD1Q-C in our study which
included of sleep vocalization in RBD1Q showed a good
consistency with “golden” criteria in diagnosing RBD pa-
tients, high sensitivity (100 %) and moderate specificity
(55.6 %) which was comparable to RBD1Q and other
screening questionnaires (Table 2). In addition, RBD1Q-
C was short and easy-to-use in large/broad epidemio-
logic surveys.
We reported a relatively high pRBD crude prevalence of
4.9 % by RBD1Q-C in comparison to other population-
based RBD prevalence studies (Table 3). This might be due
to the fact that pRBD in our prevalence study was diag-
nosed by RBD1Q-C instead of PSG. Several previous stud-
ies reported a comparative low prevalence of PSG as they
enrolled relatively severe RBD cases, for example, the
United Kingdom study investigated violent behavior during
sleep and the Hong Kong study examined sleep-related in-
jury. Interestingly, a recent study reported a prevalence of
probable RBD based RBDSQ or RBDHK as high as 4.6 %
which was similar to our results [17]. In addition, another
finding in our study was that the prevalence of pRBD was
higher in women than men, which was in contrast to the
clinical finding that RBD were more common in men than
women [18, 19]. It was possible that women might have a
less severe form of RBD [20], and therefore less likely to be
referred to a sleep clinics. Another possibility is that some
pRBD cases screened by RBD1Q-C might be RBD mimics.
Women were more likely suffer from some RBD mimics
such as insomnia [21].
In our study, we found a significant association be-
tween PD and possible RBD based on RBD1Q-C screen-
ing. This finding was consistent with several other
studies. Schenk et al. reported that 11 of 29 idiopathic
RBD (iRBD) subjects (38 %) developed parkinsonism
nearly 4 years after the diagnosis of iRBD and 13 years
after the onset of RBD symptoms [4]. In a second series,
26 of 93 iRBD patients (28 %) developed PD, DLB or
MSA after a mean follow-up of 5 years [22]. Iranzo et al.
reported that 31 of 44 iRBD patients (70.4 %) developed
a defined synucleinopathy disorder after a mean follow-
up of 10.5 years [23]. These results supported the hy-
pothesis of Braak and colleagues, which suggested that
the preclinical stages 1 and 2 of PD start at the olfactory
amd medullary area of the brainstem [24].
Some limitations should be noted. Firstly, for the valid-
ation study of RBD1Q-C, the number of subjects recruited
Table 3 Community-based prevalence studies of RBD
References Year Country Subjects Diagnostic methods Prevalence of
RBD
95 % CI
Chiu et al [10] 2000 Hong Kong A representative sample
of 1034 elderly, aged 70
years or above
Screening question, and
those who had positive
response underwent sleep
studies
0.38 % 0.01 % to 0.76 %
Ohayon et al [9] 1994–2000 Finland, Germany, Italy,
Portugal, Spain and the
United Kingdom
A random stratified sample
of 19,961 participants from
the general population,
15 years and older
telephone interview 1.7 % 1.5 % to 1.8 %
Kang et al [11] 2010 Korea Among 696 random
sampling subjects aged
60 years or older, 348
subjects underwent vPSG

















3.0 % to 7.0 %
5.6 %–10.5 %
Our study 2013 China A door-to-door survey
including 31202 residents
RBD1Q-C 4.9 % 4.6 % to 5.1 %
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was small and thus may overestimate the sensitivity, speci-
ficity, PPV and NPV. In addition, subjects who know RBD
might affect their response to the RBD1Q-C [25]. For
prevalence study, our population was from East China,
thus not representing the whole country. Also, RBD1Q-C
has moderate false-positive rates and low PPV, diagnosis
of pRBD was based on RBD1C questionnaire without PSG
confirming, which might result in an overestimation of
pRBD prevalence in our study. For PD and RBD study, we
adopted two-steps of diagnostic procedure and reached
the final diagnosis of PD by movement disorders special-
ists through exclusive investigations. However, it is pos-
sible that some mild parkinsonism cases were not
detected by local doctors and therefore affected the result
of PD-pRBD association study.
Overall, we demonstrated that a single question-based
questionnaire (RBD1Q-C) was sensitive to screen pRBD
in large population. Using this tool, we identified the
prevalence of pRBD was 4.9 % in a rural community and
associated with Parkinson’s disease.
Conclusion
RBD1Q-C was shown to be a useful screening tool with a
high sensitivity of 100 % and a moderate specificity of
55.6 %. Based on the RBD1Q-C, we found that the preva-
lence of pRBD was 4.9 % in Chinese rural population aged
≥20 years old and associated with odds of PD, calling for
more attention from patients, caregivers and physicians.
Additional file
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